Kintor Pharmaceutical Ltd.

21
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5273B1077
HKD
2.63
-0.01 (-0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Kintor Pharmaceutical Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-220.00
-166.00
-1,181.00
-1,107.00
-1,014.00
-571.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-24.00
-55.00
-106.00
-230.00
-342.00
-14.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-184.00
-214.00
-426.00
-1,116.00
-1,262.00
-427.00
Cash Flow from Investing Activities
15.00
20.00
-3.00
81.00
108.00
-495.00
Cash Flow from Financing Activities
43.00
-129.00
-36.00
948.00
1,033.00
2,000.00
Net Cash Inflow / Outflow
-124.00
-321.00
-470.00
-67.00
-164.00
976.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
-2.00
19.00
-43.00
-101.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kintor Pharmaceutical Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-220.944523700467
-113.85868607559
-107.00
-94.05%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-24.8355851895481
2.87507145579264
-26.00
-963.82%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-184.083743376346
-83.138477076427
-101.00
-121.42%
Cash Flow from Investing Activities
15.627981772113
-31.1713707213852
46.00
150.14%
Cash Flow from Financing Activities
43.6737561390001
363.932422990902
-320.00
-88.00%
Net Cash Inflow / Outflow
-124.375309201212
234.05641125307
-358.00
-153.14%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.406696264020985
-15.5661639400195
15.00
102.61%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 14.26% vs 49.68% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-184.08
-214.71
14.26%